Goodbody Health Limited
GDBYF · OTC
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2 | $2 | $5 | $7 |
| % Growth | -15.6% | -56.8% | -28% | – |
| Cost of Goods Sold | $1 | $1 | $3 | $4 |
| Gross Profit | $1 | $1 | $3 | $4 |
| % Margin | 44.9% | 45.4% | 50.4% | 50.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $1 | $1 | $1 |
| SG&A Expenses | $2 | $2 | $2 | $3 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $2 |
| Other Operating Expenses | -$1 | -$1 | $0 | $1 |
| Operating Expenses | $1 | $1 | $3 | $4 |
| Operating Income | -$1 | -$1 | $0 | $0 |
| % Margin | -52.1% | -45.5% | 1.7% | 0.4% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$1 |
| Pre-Tax Income | -$1 | -$1 | -$0 | -$1 |
| Tax Expense | $0 | -$0 | $0 | $0 |
| Net Income | -$1 | -$1 | -$0 | -$1 |
| % Margin | -67.1% | -51.3% | -5.1% | -14.6% |
| EPS | -0.035 | -0.031 | -0.007 | 0 |
| % Growth | -10.5% | -330.1% | – | – |
| EPS Diluted | -0.035 | -0.031 | -0.007 | 0 |
| Weighted Avg Shares Out | 36 | 36 | 36 | 0 |
| Weighted Avg Shares Out Dil | 36 | 36 | 36 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$1 | $0 | $0 |
| % Margin | -44.6% | -39.4% | 4.2% | 3.9% |